Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uncoupling protein 2 and islet function.

Catherine B Chan1, Monique C Saleh, Vasilij Koshkin

  • 1Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, Prince Edward, Canada. cchan@upei.ca

Diabetes
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-discharge malnutrition interventions through the lens of behavior change theory: A scoping review.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Protocol for a randomized controlled trial comparing saturated and unsaturated fat sources of a ketogenic diet (KETO-IM) investigating cardiovascular, inflammatory and immune function outcomes in adults living with overweight and prediabetes or type 2 diabetes in Edmonton, Canada.

Trials·2026
Same author

Early-life dietary long-chain polyunsaturated fatty acid consumption promotes immune function and reduces systemic and adipose inflammation in a sex-specific manner in obese Wistar rats.

The Journal of nutritional biochemistry·2026
Same author

Docosahexaenoic Acid Consumption Early in Life Improves Immune Dysfunction in High-Fat Diet-Fed Wistar Rats in a Sex-Specific Manner.

Molecular nutrition & food research·2026
Same author

Early Postpartum Glucose Tolerance Reclassification by Gestational Diabetes Subtype.

JAMA network open·2025
Same author

Nonfat Milk Supplementation Mitigates Hepatic Lipid Accumulation and Improves Hepatic Lipid Metabolism in an Early Metabolic Dysfunction-Associated Steatotic Liver Disease C57BL/6N Mouse Model.

The Journal of nutrition·2025

Uncoupling protein 2 (UCP2) negatively impacts insulin secretion and beta-cell function in type 2 diabetes. UCP2 knockout mice show improved beta-cell mass and insulin secretion under glucolipotoxic conditions.

Area of Science:

  • Endocrinology
  • Metabolic disease research
  • Molecular biology

Background:

  • Chronic hyperglycemia and hyperlipidemia are key contributors to type 2 diabetes.
  • The molecular mechanisms underlying impaired insulin secretion are under investigation.
  • Uncoupling protein 2 (UCP2) is implicated as a negative regulator of insulin secretion.

Purpose of the Study:

  • To investigate the role of UCP2 in mediating the effects of glucolipotoxicity on beta-cell function.
  • To explore the impact of UCP2 modulation on insulin secretion and beta-cell mass.

Main Methods:

  • Analysis of UCP2 expression in beta-cells under glucolipotoxic conditions.
  • Assessment of insulin secretion in the presence of altered UCP2 activity.
  • Evaluation of beta-cell mass and function in UCP2 knockout mice exposed to glucolipotoxicity.

Related Experiment Videos

Main Results:

  • Beta-cell UCP2 expression is upregulated by glucolipotoxic conditions.
  • Increased UCP2 activity is associated with decreased insulin secretion.
  • UCP2 knockout mice exhibit increased beta-cell mass and preserved insulin secretion capacity when challenged with glucolipotoxicity.

Conclusions:

  • UCP2 plays a detrimental role in insulin secretion and beta-cell function under glucolipotoxic conditions, despite potential protective effects.
  • Targeting UCP2 may represent a therapeutic strategy for type 2 diabetes by preserving beta-cell function and mass.